Cargando…
Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral
BACKGROUND: Direct acting antiviral (DAA) therapy has enabled hepatitis C virus infection to become curable, while histological changes remain uncontained. Few valid non-invasive methods can be confirmed for use in surveillance. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid (Gd-EOB-DT...
Autores principales: | Li, Xiao-He, Huang, Rui, Yang, Ming, Wang, Jian, Gao, Ying-Hui, Jin, Qian, Ma, Dan-Li, Wei, Lai, Rao, Hui-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157620/ https://www.ncbi.nlm.nih.gov/pubmed/35721884 http://dx.doi.org/10.3748/wjg.v28.i20.2214 |
Ejemplares similares
-
Liver-spleen contrast standardization of gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging based on cross-calibration
por: Mori, Hiroshige, et al.
Publicado: (2022) -
Consensus Report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging
por: Lee, Jeong Min, et al.
Publicado: (2011) -
Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery
por: Shimada, Shingo, et al.
Publicado: (2020) -
Contrast uptake in primary hepatic angiosarcoma on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the hepatobiliary phase
por: Hayashi, Manabu, et al.
Publicado: (2018) -
Preliminary clinical study of the safety of hepatectomy predicted by gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced T1 mapping magnetic resonance imaging
por: Liu, Jiao, et al.
Publicado: (2021)